Intravenous antimicrobial therapy in the community: Underused, inadequately resourced, or irrelevant to health care in Britain?

BMJ

Volumn 313, Issue 7071, 1996, Pages 1541-

  Nathwani, Dilip ^a   Davey, Peter ^a  

^a King's Cross Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIMICROBIAL THERAPY; COMMUNITY CARE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATIENT ATTITUDE; PRIORITY JOURNAL; SHORT SURVEY; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; CATCHMENT AREA (HEALTH); COMMUNITY HEALTH SERVICES; FINANCING, ORGANIZED; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFUSIONS, INTRAVENOUS; STATE MEDICINE;

EID: 0030461509     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7071.1541     Document Type: Article

References (31)

1. Antoniskis A, Anderson BC, Van Volkinburg EL, Jackson JM, Gilbert DN. Feasibility of outpatient parenteral antibiotics. West J Med 1978; 128: 203-6.
2. Balinsky W, Nesbitt S. Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature. Am J Med 1989; 87: 301-5.
3. Thickson ND. Economics of home intravenous services. Pharmaco Economics 1993; 3: 220-7.
4. Rubinstein E. Cost implications of home care on serious infections. Hosp Formul 1993; 28 (suppl1):46-50.
5. Milkovich G. Benefits of outpatient parenteral antibiotic therapy: to the individual, the institution, third-party payers and society. Int J Antimicrobial Agents 1995; 5: 27-31.
6. Malik I, Khan WA, Karim M, Aziz Z, Khan MA. Feasibility of outpatient management of fever in cancer patients with low risk neutropenia: results of a prospective randomised trial. Am J Med 1995; 98: 224-31.
7. Parker SE, Davey P. Pharmacoeconomics of intravenous drug administration. Pharmaco Economics 1992; 1: 103-15.
8. Craig WA. Selecting the antibiotic. Hospital Practice 1993; 28(suppl 1):16-20.
9. Kravitz GR. Advances in IV delivery. Hospital Practice 1993; 28 (suppl 1):21-7.
10. Enthoven A, Kronick R. A consumer-choice health plan for the 1990s: universal health insurance in a system designed to promote quality and economy (in two parts). N Engl J Med 1989; 320: 29-37, 94-101.
11. Coulter A. Shifting the balance from secondary to primary care. BMJ 1995; 311: 1447-8.
12. NHS Management Executive. Purchasing high-tech health care for patients at home. Leeds: NHSME, 1995 (EL (95)5).
13. Halls GA. The management of infections and antibiotic therapy: a European survey. J Antimicrob Chemother 1993; 31: 985-1000.
14. Non-inpatient use of parenteral antibiotics. Discussions of a national working party meeting, February 1995. In: Finch R, Davey P, eds. Home and outpatient management education. London: Medicine Group (Educational), 1995.
15. Gill S. Home administration of intravenous antibiotics to children with cystic fibrosis. Br J Nursing 1993; 2: 767-70.
16. Kohler JA. Recent advances in the management of paediatric cancer. Postgraduate Update 1991; 42: 950-8.
17. Kayley J, Berendt AR, Snelling MJM, Moore H, Hamilton HC, Peto TEA, Crook DWM, et al. Safe intravenous antibiotic therapy at home: experience of a UK based programme. J Antimicrobial Chemother 1996; 37: 1023-30.
18. Welch J, Forsey P, Graham E. Home treatment of cytomegalovirus retinitis with intravenous Ganciclovir. Genitourin Med 1990; 66: 460.
19. Postema CA. Home treatment and reimbursement in The Netherlands. Int J Antimicrobial Agents 1995; 5: 39-43.
20. Bakker W, Vinks AATMM, Mouton JW. Continue intaveneuze thuisbehandeling van luchtweginfecties met ceftazidim viaeen draagbare pomp bij patienten met cystische fibrose; een multicentrisch onderzoek. Ned Tijdschr Geneeskd 1993; 137: 2486-90.
21. Davey PG, South R, Malek M. Impact of glycopeptide therapy after hospital discharge on inpatient costs: a comparision of teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37; 623-34.
22. Lowson K. Health economics for clinician managers. Clinician in Management 1993; 2: 8-12.
23. Nolet B. Patient care issues in outpatient intravenous antibiotic therapy. Infect Dis Clin Pract 1993; 3: 225-6.
24. Schrijvers G, van der Linden B. Quality, costs and cultural beliefs in outpatient treatment with parenteral antibiotics: a comment. Int J Antimicrobial Agents 1995; 5: 45-6.
25. Kunkel MJ. Quality Assurance. Hospital Practice 1993; 28 (suppl 1):33-8.
26. Shaughnessy PW, Crisler KS, Kramer AM. Quality of care indicators in home care: preliminary indicators and directions for future research. Denver: University of Colorado Health Sciences Center, 1989.
27. Donabedian A. Evaluating the quality of medical care. Milbank Q 1966; 4: 155.
28. Graham DR. Nosohusial infections: complication of home intravenous therapy. Infect Dis Clin Pract 1993; 2: 158-61.
29. Simmons B, Trusler M, Roccaforte J, Smith P, Scott R. Infection control for home health Infect Control Hosp Epidemiol 1990; 11: 362-70.
30. Nathwani D. New option in the treatment of serious and chronic infections. Hospital Update 1995; 21: 2-3.
31. Crump BJ, Panton R, Drummond MF, Hawkes RA. Transferring the costs of expensive treatments from secondary to primary care. BMJ 1995; 310: 509-12.